Kestra Medical Technologies (KMTS) Cash from Investing Activities (2024 - 2026)
Kestra Medical Technologies (KMTS) posted quarterly Cash from Investing Activities of -$172.7 million for Q2 2026, down 2232.6% year-over-year from $8.1 million in Q2 2025, and down 1057.62% quarter-over-quarter from -$14.9 million in Q1 2026.
Kestra Medical Technologies (KMTS) Cash from Investing Activities (2024 - 2026) Analysis & Trends
Kestra Medical Technologies (KMTS) has reported Cash from Investing Activities for 3 consecutive years, with -$172.7 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash from Investing Activities fell 2232.6% year-over-year to -$172.7 million; the TTM figure through Apr 2026 stood at -$203.3 million (down 772.13% YoY), while the FY2026 annual figure was -$203.3 million, down 772.13% from the prior year.
- Cash from Investing Activities retreated to -$172.7 million in Q2 2026 per KMTS's latest filing, from -$14.9 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$4.2 million in Q2 2024 and bottomed at -$172.7 million in Q2 2026.
- Historically, Cash from Investing Activities has averaged -$25.6 million across 3 years, with a median of -$7.4 million in 2025.
- Annual changes were most pronounced in 2025 — Cash from Investing Activities decreased 17.03% — and 2026, when it slumped 2232.6%.
- Kestra Medical Technologies' Cash from Investing Activities stood at -$4.4 million in 2024, then sank by 67.87% to -$7.4 million in 2025, then tumbled by 2227.57% to -$172.7 million in 2026.
- Business Quant data shows KMTS's Cash from Investing Activities at -$172.7 million in Q2 2026, -$14.9 million in Q1 2026, and -$7.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Kestra Medical Technologies | 1.45 Bn | 1.10 Bn | 15.68 Mn | -172.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -172.71 Mn |
| Apr 30, 2026 | -172.71 Mn |
| Jan 31, 2026 | -14.92 Mn |
| Jan 31, 2026 | -14.92 Mn |
| Oct 31, 2025 | -7.42 Mn |
| Oct 31, 2025 | -7.42 Mn |
| Jul 31, 2025 | -8.23 Mn |
| Jul 31, 2025 | -8.23 Mn |
| Apr 30, 2025 | -7.40 Mn |
| Apr 30, 2025 | -7.40 Mn |
| Jan 31, 2025 | -4.45 Mn |
| Jan 31, 2025 | -4.45 Mn |
| Oct 31, 2024 | -4.42 Mn |
| Oct 31, 2024 | -4.42 Mn |
| Jul 31, 2024 | -7.03 Mn |
| Jul 31, 2024 | -7.03 Mn |
| Apr 30, 2024 | -4.16 Mn |
| Apr 30, 2024 | -4.16 Mn |